http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34622720

Outgoing Links

Predicate Object
contentType Journal Article|Randomized Controlled Trial
issn 1471-2407
issueIdentifier 1
pageRange 865-
publicationName BMC Cancer
startingPage 865
bibliographicCitation Ma T, Bai X, Wei Q, Shui Y, Lao M, Chen W, Huang B, Que R, Gao S, Zhang Y, Chen W, Wang J, Liang T. Adjuvant therapy with gemcitabine and stereotactic body radiation therapy versus gemcitabine alone for resected stage II pancreatic cancer: a prospective, randomized, open-label, single center trial. BMC Cancer. 2022 Aug 08;22(1):865. PMID: 35941566; PMCID: PMC9361660.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_595451720e445b71f2fd266ae5f10902
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_488f13e2d087ec09b27d89a15da1aafd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9137fe389d3788dfc8786b5f58f9a09a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b1d3ef8f4ab8375b12a928dff5422bdd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c57f39789ab1db2f6e79fb8588b24015
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db4b68cdc6115f5db775bac1ef466b0f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_52d025635ac7e6ea97cdebfd06925155
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4a2f653569f5d3472f5613b39c3cfe2f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_257ec99c92ed08eee71e36a5b05f4bc9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_42592f131eb1a84bc7e312cbe2422c35
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7c1d87abe38d3e5af19fae3c10a18bc3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7a44564043fa6e9bde5e5029644836ce
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e4a85484619fe0fb66fcb0ccc354814d
date 2022-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/35941566
https://doi.org/10.1186/s12885-022-09974-7
https://pubmed.ncbi.nlm.nih.gov/PMC9361660
isPartOf https://portal.issn.org/resource/ISSN/1471-2407
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22020
language English
source https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/
title Adjuvant therapy with gemcitabine and stereotactic body radiation therapy versus gemcitabine alone for resected stage II pancreatic cancer: a prospective, randomized, open-label, single center trial
discusses http://id.nlm.nih.gov/mesh/M000754277
http://id.nlm.nih.gov/mesh/M0005997
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8766
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7317

Total number of triples: 37.